Anjelica Gonzalez is an associate professor of biomedical engineering and part of the vascular biology and therapeutics program. Gonzalez’s research focuses on the development of biomimetic materials for use in investigation of immunology, inflammation, and fibrosis.
Gonzalez has a dedicated interest in training the next generation of scientists to think in an interdisciplinary way and approach problems from a scientifically global perspective. With a multidisciplinary approach, the Gonzalez Lab combines organic chemistry, molecular biology, mathematics, computational modeling, and image analysis to develop and use engineered scaffolds to dissect the chemo-mechanics of immunological processes. This work has led to significant advancements specific to an array of diseases and disorders, including vascular inflammation, stroke, fibrosis, and sepsis.
Gonzalez's translational research interests have led to the development of new technologies that are being deployed in underserved and low-infrastructure settings across the world. PremieBreathe, a low-cost, mobile neonatal respiratory device invented by Gonzalez, has been supported by the U.S. Agency for International Development (USAID), the Bill and Melinda Gates Foundation, and NCIIA/Venturewell for development and study deployment in Ethiopia.
Gonzalez has been recognized for her dedication to exceptional teaching, having been awarded Yale’s Provost’s Teaching Award, the top prize awarded for teaching across all of Yale University, including Yale College, Yale School of Medicine, School of Management, and Yale Law School. Her efforts in education and public inclusion in science is noted by her opinion pieces published in Science and the New York Times. In July 2022, Gonzalez was appointed as the new Davenport head of college. She is the first Black woman to serve as head of college in Yale’s history.